BG62965B1 - Производни на хинолон-и нафтиридонкарбонови киселини - Google Patents

Производни на хинолон-и нафтиридонкарбонови киселини Download PDF

Info

Publication number
BG62965B1
BG62965B1 BG100041A BG10004195A BG62965B1 BG 62965 B1 BG62965 B1 BG 62965B1 BG 100041 A BG100041 A BG 100041A BG 10004195 A BG10004195 A BG 10004195A BG 62965 B1 BG62965 B1 BG 62965B1
Authority
BG
Bulgaria
Prior art keywords
methyl
oxo
acid
hydrogen
dihydro
Prior art date
Application number
BG100041A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG100041A (bg
Inventor
Uwe Petersen
Thomas Schenke
Klaus-Dieter Bremm
Rainer Endermann
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG100041A publication Critical patent/BG100041A/bg
Publication of BG62965B1 publication Critical patent/BG62965B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
BG100041A 1994-10-04 1995-10-02 Производни на хинолон-и нафтиридонкарбонови киселини BG62965B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4435479A DE4435479A1 (de) 1994-10-04 1994-10-04 Chinolon- und Naphthyridoncarbonsäure-Derivate

Publications (2)

Publication Number Publication Date
BG100041A BG100041A (bg) 1996-05-31
BG62965B1 true BG62965B1 (bg) 2000-12-29

Family

ID=6529941

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100041A BG62965B1 (bg) 1994-10-04 1995-10-02 Производни на хинолон-и нафтиридонкарбонови киселини

Country Status (40)

Country Link
US (1) US5679689A (cs)
EP (1) EP0705828B1 (cs)
JP (1) JP3794737B2 (cs)
KR (1) KR100371883B1 (cs)
CN (1) CN1063747C (cs)
AT (1) ATE187171T1 (cs)
AU (1) AU697608B2 (cs)
BG (1) BG62965B1 (cs)
CA (1) CA2159547A1 (cs)
CO (1) CO4480031A1 (cs)
CU (1) CU22751A3 (cs)
CZ (1) CZ291616B6 (cs)
DE (2) DE4435479A1 (cs)
DK (1) DK0705828T3 (cs)
DZ (1) DZ1933A1 (cs)
EE (1) EE03443B1 (cs)
ES (1) ES2140599T3 (cs)
FI (1) FI954680L (cs)
GR (1) GR3032659T3 (cs)
HR (1) HRP950469B1 (cs)
HU (1) HUT73429A (cs)
IL (2) IL115492A (cs)
MA (1) MA23682A1 (cs)
MY (1) MY113196A (cs)
NO (1) NO307514B1 (cs)
NZ (1) NZ280129A (cs)
PE (1) PE29698A1 (cs)
PL (1) PL182812B1 (cs)
PT (1) PT705828E (cs)
RO (1) RO115261B1 (cs)
RU (1) RU2145604C1 (cs)
SG (1) SG38880A1 (cs)
SI (1) SI0705828T1 (cs)
SK (1) SK280877B6 (cs)
SV (1) SV1995000063A (cs)
TN (1) TNSN95099A1 (cs)
TW (1) TW364908B (cs)
UA (1) UA42797C2 (cs)
YU (1) YU63595A (cs)
ZA (1) ZA958296B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US8163769B2 (en) * 2002-03-12 2012-04-24 Abbott Laboratories Antibacterial compounds
MXPA05009688A (es) * 2003-03-12 2005-12-05 Abbott Lab Derivados de naftiridina como agentes antibacterianos.
RU2443698C2 (ru) 2007-01-05 2012-02-27 Дайити Санкио Компани, Лимитед Конденсированное замещенное производное аминопирролидина
IL293213A (en) 2019-11-28 2022-07-01 Bayer Ag Substituted aminoquinolones as dgkalpha inhibitors for immune activation
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPH0262875A (ja) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
CA2030217A1 (en) * 1989-11-21 1991-05-22 Jun Imose Pyridone-carboxylic acid derivatives useful as veterinary medicines
JPH03181478A (ja) * 1989-12-08 1991-08-07 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
JPH04253973A (ja) 1990-04-20 1992-09-09 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
WO1992012146A1 (en) * 1990-12-27 1992-07-23 Banyu Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
DE4329600A1 (de) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
WO1995021163A1 (en) * 1994-02-04 1995-08-10 Dainippon Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate

Also Published As

Publication number Publication date
FI954680A7 (fi) 1996-04-05
MA23682A1 (fr) 1996-07-01
EP0705828B1 (de) 1999-12-01
CZ256895A3 (en) 1996-04-17
SK280877B6 (sk) 2000-08-14
PE29698A1 (es) 1998-08-27
ZA958296B (en) 1996-05-07
SV1995000063A (es) 1996-07-24
EE9500069A (et) 1996-04-15
HUT73429A (en) 1996-07-29
EP0705828A1 (de) 1996-04-10
NZ280129A (en) 1996-06-25
BG100041A (bg) 1996-05-31
PT705828E (pt) 2000-04-28
YU63595A (sh) 1998-08-14
JPH08225567A (ja) 1996-09-03
DZ1933A1 (fr) 2002-02-17
SK123895A3 (en) 1996-06-05
HRP950469A2 (en) 1997-08-31
EE03443B1 (et) 2001-06-15
NO953931L (no) 1996-04-09
RU2145604C1 (ru) 2000-02-20
CN1063747C (zh) 2001-03-28
NO307514B1 (no) 2000-04-17
DE59507324D1 (de) 2000-01-05
AU697608B2 (en) 1998-10-15
CA2159547A1 (en) 1996-04-05
JP3794737B2 (ja) 2006-07-12
SI0705828T1 (en) 2000-02-29
SG38880A1 (en) 1997-04-17
DE4435479A1 (de) 1996-04-11
ES2140599T3 (es) 2000-03-01
US5679689A (en) 1997-10-21
PL310747A1 (en) 1996-04-15
TW364908B (en) 1999-07-21
NO953931D0 (no) 1995-10-03
KR960014118A (ko) 1996-05-22
FI954680L (fi) 1996-04-05
CZ291616B6 (cs) 2003-04-16
GR3032659T3 (en) 2000-06-30
IL115492A0 (en) 1996-01-19
PL182812B1 (pl) 2002-03-29
TNSN95099A1 (fr) 1996-02-06
FI954680A0 (fi) 1995-10-02
CN1126211A (zh) 1996-07-10
UA42797C2 (uk) 2001-11-15
MY113196A (en) 2001-12-31
RO115261B1 (ro) 1999-12-30
IL115492A (en) 1999-12-22
IL130921A (en) 2001-10-31
AU3291995A (en) 1996-04-18
HRP950469B1 (en) 2000-12-31
KR100371883B1 (ko) 2003-03-29
DK0705828T3 (da) 2000-05-15
ATE187171T1 (de) 1999-12-15
HU9502888D0 (en) 1995-11-28
CO4480031A1 (es) 1997-07-09
CU22751A3 (es) 2002-02-28

Similar Documents

Publication Publication Date Title
FI94251B (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydro-4-okso-3-kinoliinikarboksyylihappojohdannaisten ja niiden additiotuotteiden veden, happojen ja emästen kanssa, valmistamiseksi
EP0529688B1 (en) Azaspiro(n,m)alkanes and diazaspiro(n,m)-alkanes
JPH05213947A (ja) 7−アザイソインドリニル−キノロン−及びナフチリドンカルボン酸誘導体
JPH05271229A (ja) キノロン−およびナフチリドン−カルボン酸誘導体類
JP3199930B2 (ja) 7−イソインドリニル−キノロン誘導体および7−イソインドリニル−ナフチリドン誘導体
BG62965B1 (bg) Производни на хинолон-и нафтиридонкарбонови киселини
JP2807277B2 (ja) スピロ化合物
US5605910A (en) Quinolone-and naphthyridonecarboxylic acid derivatives
JPH07188230A (ja) 1−(2−フルオロシクロプロピル)−キノロンカルボン酸および1−(2−フルオロシクロプロピル)−ナフチリドンカルボン酸誘導体
JPH06192262A (ja) 7−(アミノメチル−オキサ−7−アザ−ビシクロ[3.3.0]オクト−7−イル)キノロンカルボン酸および7−(アミノメチル−オキサ−7−アザ−ビシクロ[3.3.0]オクト−7−イル)ナフチリドンカルボン酸誘導体
JPH07300472A (ja) 新規キノロンカルボン酸誘導体およびその製造方法
US5703094A (en) Quinolone- and naphthyridonecarboxylic acid derivatives
RU2094432C1 (ru) Спиросоединение или его соли, способ его получения и фармацевтическая композиция на его основе, обладающая противомикробной активностью
JPH08333337A (ja) スピロ化合物
JPH0348682A (ja) ピリドンカルボン酸化合物
IE19970856A1 (en) 7-(1-Pyrrolidinyl)-3-quinolone and naphthyridone carboxylic acid derivatives, method for their preparation and for substituted mono- and bicyclic pyrrolidine intermediates, and their antibacterial and feed additive compositions